Literature DB >> 24010405

Effects of short interfering RNA-mediated gene silencing of SKA1 on proliferation of hepatocellular carcinoma cells.

Xihu Qin1, Bo Yuan, Xintao Xu, Hai Huang, Yong Liu.   

Abstract

BACKGROUND: Hepatocellular carcinoma (HCC) is one of the common causes of cancer resulting in death in China. Here, we found that spindle- and kinetochore-associated complex subunit 1 (SKA1) is a critical factor that plays an essential role in the regulation of HCC cell proliferation and apoptosis.
METHODS: Using immunohistochemistry in 38 HCC tissues, we showed that the expression of SKA1 was upregulated in HCC tissues compared with the normal tissues. Then, we investigated the effects of SKA1-targeted small interfering RNA (siRNA) on the HCC cell proliferation and apoptosis as of HCC cells. SKA1-targeted siRNA was delivered to HCC SMMC-7721 and Bel-7404 cells to evaluate its antiproliferation effects using lentivirus.
RESULTS: The lentivirus-mediated siRNA-targeting SKA1 treatment leads to a significant (p < 0.01) downregulation of SKA1 expression at mitochondrial RNA (mRNA) level. Knockdown of SKA1 inhibited HCC cell proliferation by inducing cell cycle arrest in the G0/G1 phase. Furthermore, lentivirus-mediated siRNA efficiently inhibited cell proliferation and colony formation while promoting the apoptosis.
CONCLUSIONS: Of note, our data suggest that SKA1 might play an important role in the proliferation of HCC cells, and the absence of this gene in HCC may open promising therapeutic approaches for HCC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24010405     DOI: 10.3109/00365521.2013.828774

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  10 in total

Review 1.  Targeting mitotic pathways for endocrine-related cancer therapeutics.

Authors:  Shivangi Agarwal; Dileep Varma
Journal:  Endocr Relat Cancer       Date:  2017-06-14       Impact factor: 5.678

2.  Hypoxia promotes chemotherapy resistance by down-regulating SKA1 gene expression in human osteosarcoma.

Authors:  Qiong Ma; Yinglong Zhang; Tao Liu; Kuo Jiang; Yanhua Wen; Qingyu Fan; Xiuchun Qiu
Journal:  Cancer Biol Ther       Date:  2017-02-17       Impact factor: 4.742

3.  Identification of Spindle and Kinetochore-Associated Family Genes as Therapeutic Targets and Prognostic Biomarkers in Pancreas Ductal Adenocarcinoma Microenvironment.

Authors:  Yi Liu; Zong-Rui Jin; Xing Huang; Ye-Cheng Che; Qin Liu
Journal:  Front Oncol       Date:  2020-11-02       Impact factor: 6.244

4.  Expression of Spindle and Kinetochore-Associated Protein 1 Is Associated with Poor Prognosis in Papillary Thyroid Carcinoma.

Authors:  Chao Dong; Xiao-li Wang; Bin-lin Ma
Journal:  Dis Markers       Date:  2015-05-04       Impact factor: 3.434

5.  Expression and function analysis of mitotic checkpoint genes identifies TTK as a potential therapeutic target for human hepatocellular carcinoma.

Authors:  Xiao-Dong Liang; Yue-Chu Dai; Zhao-Yun Li; Mei-Fu Gan; Shi-Rong Zhang; Hong-Sheng Lu; Xue-Quan Cao; Bei-jia Zheng; Ling-Fen Bao; Dan-Dan Wang; Li-Ming Zhang; Sheng-Lin Ma
Journal:  PLoS One       Date:  2014-06-06       Impact factor: 3.240

6.  SKA1 regulates the metastasis and cisplatin resistance of non-small cell lung cancer.

Authors:  Lihua Shen; Min Yang; Qionghua Lin; Zhongwei Zhang; Changhong Miao; Biao Zhu
Journal:  Oncol Rep       Date:  2016-03-10       Impact factor: 3.906

7.  Regulation of spindle and kinetochore-associated protein 1 by antitumor miR-10a-5p in renal cell carcinoma.

Authors:  Takayuki Arai; Atsushi Okato; Satoko Kojima; Tetsuya Idichi; Keiichi Koshizuka; Akira Kurozumi; Mayuko Kato; Kazuto Yamazaki; Yasuo Ishida; Yukio Naya; Tomohiko Ichikawa; Naohiko Seki
Journal:  Cancer Sci       Date:  2017-08-19       Impact factor: 6.716

8.  Identification of biomarkers of chromophobe renal cell carcinoma by weighted gene co-expression network analysis.

Authors:  Xiaomao Yin; Jianfeng Wang; Jin Zhang
Journal:  Cancer Cell Int       Date:  2018-12-17       Impact factor: 5.722

9.  SKA1 overexpression is associated with poor prognosis in hepatocellular carcinoma.

Authors:  Yibing Chen; Jingjing Zhao; Zhihui Jiao; Weiwei Wang; Dandan Wang; Xiaohe Yu; Zhiyong Shi; Naijian Ge; Qiuzhong Pan; Jianchuan Xia; Wancheng Niu; Ruihua Zhao; Xiaofei Zhang; Wei Du
Journal:  BMC Cancer       Date:  2018-12-11       Impact factor: 4.430

10.  SKA1 promotes malignant phenotype and progression of glioma via multiple signaling pathways.

Authors:  Xizhao Wang; Yu Zeng; Mingfeng Zhou; Xian Zhang; Anqi Xu; Jie Lin; Zhiyong Wu; Cheng Xie; Jie Luo; Shengfeng Ding; Zhengming Zhan; Hao Long; Ye Song
Journal:  Cancer Cell Int       Date:  2019-12-03       Impact factor: 5.722

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.